The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for MP Wentland


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
24
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives.EBI
Sterling Winthrop Pharmaceuticals Research Division
4
Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative.EBI
Sterling-Winthrop Research Institute
17
Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivatives.EBI
TBA
9
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors.EBI
Rensselaer Polytechnic Institute
24
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC.EBI
Rensselaer Polytechnic Institute
22
Syntheses of novel high affinity ligands for opioid receptors.EBI
Rensselaer Polytechnic Institute
41
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.EBI
Rensselaer Polytechnic Institute
20
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.EBI
Rensselaer Polytechnic Institute
21
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC.EBI
Institute
17
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.EBI
Rensselaer Polytechnic Institute
6
Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone.EBI
Rensselaer Polytechnic Institute
9
Selective protection and functionalization of morphine: synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives.EBI
Rensselaer Polytechnic Institute
8
3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.EBI
Pharmacia
16
8-Aminocyclazocine analogues: synthesis and structure-activity relationships.EBI
Institute
23
 
The antitumor activity of novel pyrazoloquinoline derivativesEBI
TBA
7
 
Arylacetamide kappa-selective opioid ligandsEBI
TBA
11
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine.EBI
Rensselaer Polytechnic Institute
37
10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.EBI
Harvard Medical School
16
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues.EBI
Rensselaer Polytechnic Institute
43
Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.EBI
Rensselaer Polytechnic Institute
14
8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines.EBI
Rensselaer Polytechnic Institute
24
Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.EBI
Sanofi Winthrop
15
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6-6 fused rings as alternative S1 moieties.BDB
Daiichi Sankyo